Syngene International Limited Bombay S.E.
Equities
SYNGENE
INE398R01022
Biotechnology & Medical Research
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
694.2 INR | -1.00% | -2.24% | -0.99% |
Apr. 24 | Syngene International Limited Recommends Final Dividend for the Financial Year 2024 | CI |
Apr. 24 | Syngene International Limited Reports Earnings Results for the Full Year Ended March 31, 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+4.09% | 43.43B | |
+47.81% | 41.69B | |
+9.45% | 41.31B | |
-10.92% | 27.14B | |
+9.32% | 25.28B | |
-24.87% | 18.47B | |
+29.70% | 12.59B | |
+1.28% | 12.33B | |
+7.78% | 11.03B |
- Stock Market
- Equities
- SYNGENE Stock
- SYNGENE Stock
- News Syngene International Limited
- Syngene International : Posts Higher Profit in January-March